Jürgen Conrad (PhD), is founder and managing director of ConsulTech GmbH. He has more than 25 years experience in life science industry. The projects which received public grants showed a broad range of subjects from nano materials for dental applications, oncology, neurology, infectious diseases, heart valves to molecular imaging and IVD.
ConsulTech published several studies and articles about German biotech industry and public funding of companies.
During his time with Schering AG Jürgen Conrad filed numerous patents in diagnostic imaging and is also inventor of Primovist® (Bayer). Primovist® is an innovative liver-specific contrast agent for MRI that significantly improves both detection and characterization of focal liver lesion.